The effectiveness of treatment of pulmonary tuberculosis depending on CYP3A4 genotype

Poludenko, H. A.; Antonenko, P. B.; Rozhkovskyi, Y. V.; Antonenko, K. A.; Lobashova, K. G.

dc.contributor.author	Poludenko, H. A.	en
dc.contributor.author	Antonenko, P. B.	en
dc.contributor.author	Rozhkovskyi, Y. V.	en
dc.contributor.author	Antonenko, K. A.	en
dc.contributor.author	Lobashova, K. G.	en
dc.date.accessioned	2023-01-24T20:16:59Z
dc.date.available	2023-01-24T20:16:59Z
dc.date.issued	2022
dc.identifier.citation	The effectiveness of treatment of pulmonary tuberculosis depending on CYP3A4 genotype / H. A. Poludenko, P. B. Antonenko, Y. V. Rozhkovsky et al. // Ukr. Pulmonol. J. 2022. No 30(1). P. 62–66.	en
dc.identifier.uri	https://repo.odmu.edu.ua:443/xmlui/handle/123456789/12010
dc.description.abstract	Among the factors that can influence the course and effectiveness of the treatment of pulmonary tuberculosis (TB) the genetic characteristics of patients play an important role. It is established that cytochrome (CYP) 3A4/5 is involved in metabolism of more than 30 % of xenobiotics. Consequently, the activity of this enzyme is greatly influenced by responsible genes, such as CYP3А4.	en
dc.language.iso	en	en
dc.subject	pulmonary tuberculosis	en
dc.subject	anti-tuberculosis therapy	en
dc.title	The effectiveness of treatment of pulmonary tuberculosis depending on CYP3A4 genotype	en
dc.type	Article	en